The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
0.30 end Oct I will be happy with that. Also need to make sure am not smoking stuff.
Actually maybe we should be grateful that JW's pumping, if it was not for this, then the SP might be more depressed. That said the fundmentals have to catch up.
Lead variety. Underwater already, and more so courtesy of this morning's damp squib.
My avg is above that. Looks like I am going to be waiting a very, very long time.
Are you in this Barnetpeter?
Hello, has anyone done a comparison of Cizzle and Lunglife AI ? Both have the same objective, early detection of lung cancer...
@LT thanks for the maths here - appreciated! Gives some quantification.
It might just about hold up this time, I'd not want to sell as it's looking substantially derisked now
Wonder what quantity this means (how many sectors, at estimated target of 100 each), and anyone know the price per unit?
"Once the medical license in China has been secured in 2022, HZH and the Company estimate a target rising to 100 units per annum for each therapeutic drug monitoring sector over the next two to three years, and there several sectors in this market and in other analytical sectors. HZH has confirmed it can meet the prospective demand requirements of Microsaic for China and the rest of the world."
Well you must have been listening to the wrong presentation. I thought it was a good review of the business and it's future prospects. If mode had not been spikey from the BTC/ARB maneuvers in Q1, and taken advantage of that with the 55p raise, then today's sp would not seem so bad. I'm a holder, under water of course, any will continue to be so.
I admire your positive sentiment neutronic, but you are referring to our current government, so.....
Fabulous, as you say. However...
....seems no one interested in AMTE, in fact is this looking like it's getting back to the listing price real soon now. What's gone wrong (or not yet gone right?)
Yeah, don't both with those bb's any more. 2022's the time to look again, I guess. So be it.
Well IGAS is rocking, indeed. What's happened there. Why am I always in the wrong fking share?!! Gawd.
Just put Buster in the bin, simples.
No reddies. Full up at ABDX and AVCT, in both cases at significantly higher averages than where we are now. I need this to have a positive lift like we're expecting, just to get to even. Ho hum!
Anyone know if there is one? Details?
Agree, good RNS (apart from the brutal truth that sales oppos for the antibody test, as collaboratively build for the UK Government is basically becalmed). Following the approvals, however we need sales, and the market is, somewhat, jammed packed with vendors that got their approval a long, long time ago and have containers and warehouses full of their stock they will happily offload at whatever price. Maybe. Sad LTH since early 2020 here, btw, before you shoot me. Just setting out the risks.
No placing IMHO, I reckon MOS have cash for some runway anyway, and with business cranking the way it is there may be organic growth soon enough too. Holding here for the longer term, the only way is up for MOS. DYOR.